Companies House 2023-11-01 2024-10-31 2024-10-31 false true iso4217:GBP xbrli:pure SC189762 2022-11-01 2023-10-31 SC189762 2024-10-31 SC189762 2023-11-01 2024-10-31 SC189762 2023-10-31 SC189762 curr:PoundSterling 2023-11-01 2024-10-31 SC189762 uk-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 SC189762 uk-bus:FRS102 2023-11-01 2024-10-31 SC189762 uk-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 SC189762 uk-bus:AbridgedAccounts 2023-11-01 2024-10-31 SC189762 uk-bus:RegisteredOffice 2023-11-01 2024-10-31 SC189762 uk-bus:Director40 2023-11-01 2024-10-31 SC189762 uk-bus:Director1 2023-11-01 2024-10-31 SC189762 uk-bus:Director2 2023-11-01 2024-10-31 SC189762 uk-bus:Director3 2023-11-01 2024-10-31 SC189762 uk-bus:Director4 2023-11-01 2024-10-31 SC189762 uk-bus:Director5 2023-11-01 2024-10-31 SC189762 uk-bus:Director6 2023-11-01 2024-10-31 SC189762 uk-bus:Director7 2023-11-01 2024-10-31 SC189762 uk-bus:Director8 2023-11-01 2024-10-31 SC189762 uk-bus:Director9 2023-11-01 2024-10-31 SC189762 uk-bus:Director10 2023-11-01 2024-10-31 SC189762 uk-bus:Director11 2023-11-01 2024-10-31 SC189762 uk-bus:Director12 2023-11-01 2024-10-31 SC189762 uk-bus:Director13 2023-11-01 2024-10-31 SC189762 uk-bus:Director14 2023-11-01 2024-10-31 SC189762 uk-bus:Director15 2023-11-01 2024-10-31 SC189762 uk-bus:Director16 2023-11-01 2024-10-31 SC189762 uk-bus:Director17 2023-11-01 2024-10-31 SC189762 uk-bus:Director18 2023-11-01 2024-10-31 SC189762 uk-bus:Director19 2023-11-01 2024-10-31 SC189762 uk-bus:Director20 2023-11-01 2024-10-31 SC189762 uk-bus:CompanySecretary1 2023-11-01 2024-10-31 SC189762 core:AfterOneYear 2024-10-31 SC189762 core:AfterOneYear 2023-10-31 SC189762 core:WithinOneYear 2024-10-31 SC189762 core:WithinOneYear 2023-10-31 SC189762 core:WithinOneYear 2023-11-01 2024-10-31 SC189762 core:AfterOneYear 2024-10-31 SC189762 core:AfterOneYear 2023-10-31 SC189762 core:AfterOneYear 2023-11-01 2024-10-31 SC189762 core:ShareCapital 2024-10-31 SC189762 core:ShareCapital 2023-10-31 SC189762 core:SharePremium 2024-10-31 SC189762 core:SharePremium 2023-10-31 SC189762 core:OtherReservesSubtotal 2024-10-31 SC189762 core:OtherReservesSubtotal 2023-10-31 SC189762 core:RevaluationReserve 2024-10-31 SC189762 core:RevaluationReserve 2023-10-31 SC189762 core:RetainedEarningsAccumulatedLosses 2024-10-31 SC189762 core:RetainedEarningsAccumulatedLosses 2023-10-31 SC189762 core:Associate1 2023-11-01 2024-10-31 SC189762 core:Associate1 2023-10-31 SC189762 core:Associate1 2024-10-31 SC189762 core:Associate2 2023-11-01 2024-10-31 SC189762 core:Associate2 2023-10-31 SC189762 core:Associate2 2024-10-31 SC189762 core:Associate3 2023-11-01 2024-10-31 SC189762 core:Associate3 2023-10-31 SC189762 core:Associate3 2024-10-31 SC189762 core:Associate4 2023-11-01 2024-10-31 SC189762 core:Associate4 2023-10-31 SC189762 core:Associate4 2024-10-31 SC189762 core:Associate5 2023-11-01 2024-10-31 SC189762 core:Associate5 2023-10-31 SC189762 core:Associate5 2024-10-31 SC189762 core:Associate6 2023-11-01 2024-10-31 SC189762 core:Associate6 2023-10-31 SC189762 core:Associate6 2024-10-31 SC189762 core:Associate7 2023-11-01 2024-10-31 SC189762 core:Associate7 2023-10-31 SC189762 core:Associate7 2024-10-31 SC189762 core:Associate8 2023-11-01 2024-10-31 SC189762 core:Associate8 2023-10-31 SC189762 core:Associate8 2024-10-31 SC189762 core:Associate9 2023-11-01 2024-10-31 SC189762 core:Associate9 2023-10-31 SC189762 core:Associate9 2024-10-31 SC189762 core:Associate10 2023-11-01 2024-10-31 SC189762 core:Associate10 2023-10-31 SC189762 core:Associate10 2024-10-31 SC189762 core:Associate11 2023-11-01 2024-10-31 SC189762 core:Associate11 2023-10-31 SC189762 core:Associate11 2024-10-31 SC189762 core:Associate12 2023-11-01 2024-10-31 SC189762 core:Associate12 2023-10-31 SC189762 core:Associate12 2024-10-31 SC189762 core:Associate13 2023-11-01 2024-10-31 SC189762 core:Associate13 2023-10-31 SC189762 core:Associate13 2024-10-31 SC189762 core:Associate14 2023-11-01 2024-10-31 SC189762 core:Associate14 2023-10-31 SC189762 core:Associate14 2024-10-31 SC189762 core:Associate15 2023-11-01 2024-10-31 SC189762 core:Associate15 2023-10-31 SC189762 core:Associate15 2024-10-31 SC189762 core:Associate16 2023-11-01 2024-10-31 SC189762 core:Associate16 2023-10-31 SC189762 core:Associate16 2024-10-31 SC189762 core:Associate17 2023-11-01 2024-10-31 SC189762 core:Associate17 2023-10-31 SC189762 core:Associate17 2024-10-31 SC189762 core:Associate18 2023-11-01 2024-10-31 SC189762 core:Associate18 2023-10-31 SC189762 core:Associate18 2024-10-31 SC189762 core:Associate19 2023-11-01 2024-10-31 SC189762 core:Associate19 2023-10-31 SC189762 core:Associate19 2024-10-31 SC189762 core:Associate20 2023-11-01 2024-10-31 SC189762 core:Associate20 2023-10-31 SC189762 core:Associate20 2024-10-31 SC189762 core:Associate1 2023-11-01 2024-10-31 SC189762 core:Associate2 2023-11-01 2024-10-31 SC189762 core:Associate3 2023-11-01 2024-10-31 SC189762 core:Associate4 2023-11-01 2024-10-31 SC189762 core:Associate5 2023-11-01 2024-10-31 SC189762 core:Associate6 2023-11-01 2024-10-31 SC189762 core:Associate7 2023-11-01 2024-10-31 SC189762 core:Associate8 2023-11-01 2024-10-31 SC189762 core:Associate9 2023-11-01 2024-10-31 SC189762 core:Associate10 2023-11-01 2024-10-31 SC189762 core:Associate11 2023-11-01 2024-10-31 SC189762 core:Associate12 2023-11-01 2024-10-31 SC189762 core:Associate13 2023-11-01 2024-10-31 SC189762 core:Associate14 2023-11-01 2024-10-31 SC189762 core:Associate15 2023-11-01 2024-10-31 SC189762 core:Associate16 2023-11-01 2024-10-31 SC189762 core:Associate17 2023-11-01 2024-10-31 SC189762 core:Associate18 2023-11-01 2024-10-31 SC189762 core:Associate19 2023-11-01 2024-10-31 SC189762 core:Associate20 2023-11-01 2024-10-31 SC189762 uk-bus:Director1 1 2023-11-01 2024-10-31 SC189762 uk-bus:Director1 1 2023-10-31 SC189762 uk-bus:Director1 1 2024-10-31 SC189762 uk-bus:Director2 2 2023-11-01 2024-10-31 SC189762 uk-bus:Director2 2 2023-10-31 SC189762 uk-bus:Director2 2 2024-10-31 SC189762 uk-bus:Director1 3 2023-11-01 2024-10-31 SC189762 uk-bus:Director1 3 2023-10-31 SC189762 uk-bus:Director1 3 2024-10-31 SC189762 uk-bus:Director4 4 2023-11-01 2024-10-31 SC189762 uk-bus:Director4 4 2023-10-31 SC189762 uk-bus:Director4 4 2024-10-31 SC189762 uk-bus:Director5 5 2023-11-01 2024-10-31 SC189762 uk-bus:Director5 5 2023-10-31 SC189762 uk-bus:Director5 5 2024-10-31 SC189762 uk-bus:Director6 6 2023-11-01 2024-10-31 SC189762 uk-bus:Director6 6 2023-10-31 SC189762 uk-bus:Director6 6 2024-10-31 SC189762 uk-bus:Director7 7 2023-11-01 2024-10-31 SC189762 uk-bus:Director7 7 2023-10-31 SC189762 uk-bus:Director7 7 2024-10-31 SC189762 uk-bus:Director8 8 2023-11-01 2024-10-31 SC189762 uk-bus:Director8 8 2023-10-31 SC189762 uk-bus:Director8 8 2024-10-31 SC189762 uk-bus:Director9 9 2023-11-01 2024-10-31 SC189762 uk-bus:Director9 9 2023-10-31 SC189762 uk-bus:Director9 9 2024-10-31 SC189762 uk-bus:Director10 10 2023-11-01 2024-10-31 SC189762 uk-bus:Director10 10 2023-10-31 SC189762 uk-bus:Director10 10 2024-10-31 SC189762 uk-bus:Director11 11 2023-11-01 2024-10-31 SC189762 uk-bus:Director11 11 2023-10-31 SC189762 uk-bus:Director11 11 2024-10-31 SC189762 uk-bus:Director12 12 2023-11-01 2024-10-31 SC189762 uk-bus:Director12 12 2023-10-31 SC189762 uk-bus:Director12 12 2024-10-31 SC189762 uk-bus:Director13 13 2023-11-01 2024-10-31 SC189762 uk-bus:Director13 13 2023-10-31 SC189762 uk-bus:Director13 13 2024-10-31 SC189762 uk-bus:Director14 14 2023-11-01 2024-10-31 SC189762 uk-bus:Director14 14 2023-10-31 SC189762 uk-bus:Director14 14 2024-10-31 SC189762 uk-bus:Director15 15 2023-11-01 2024-10-31 SC189762 uk-bus:Director15 15 2023-10-31 SC189762 uk-bus:Director15 15 2024-10-31 SC189762 uk-bus:Director16 16 2023-11-01 2024-10-31 SC189762 uk-bus:Director16 16 2023-10-31 SC189762 uk-bus:Director16 16 2024-10-31 SC189762 uk-bus:Director17 17 2023-11-01 2024-10-31 SC189762 uk-bus:Director17 17 2023-10-31 SC189762 uk-bus:Director17 17 2024-10-31 SC189762 uk-bus:Director18 18 2023-11-01 2024-10-31 SC189762 uk-bus:Director18 18 2023-10-31 SC189762 uk-bus:Director18 18 2024-10-31 SC189762 uk-bus:Director19 19 2023-11-01 2024-10-31 SC189762 uk-bus:Director19 19 2023-10-31 SC189762 uk-bus:Director19 19 2024-10-31 SC189762 uk-bus:Director20 20 2023-11-01 2024-10-31 SC189762 uk-bus:Director20 20 2023-10-31 SC189762 uk-bus:Director20 20 2024-10-31 SC189762 1 2023-11-01 2024-10-31 SC189762 2 2023-11-01 2024-10-31 SC189762 3 2023-11-01 2024-10-31

# REGENCY MEDICINE LTD.

## Company Registration Number:
SC189762 (Scotland)

## Unaudited abridged accounts for the year ended 31 October 2024

## Period of accounts

## Start date: 01 November 2023

## End date: 31 October 2024

# REGENCY MEDICINE LTD.

## Contents of the Financial Statements

for the Period Ended 31 October 2024

Balance sheet |
Notes |

# REGENCY MEDICINE LTD.

## Balance sheet

As at 31 October 2024

| Notes | 2024 | 2023
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 567,577 | 611,466
Total fixed assets: |  | 567,577 | 611,466
Current assets
Stocks: |  | 3,000 | 3,000
Debtors: | 4 | 1,768,020 | 1,585,449
Cash at bank and in hand: |  | 46,282 | 58,409
Total current assets: |  | 1,817,302 | 1,646,858
Creditors: amounts falling due within one year: | 5 | (236,222) | (169,082)
Net current assets (liabilities): |  | 1,581,080 | 1,477,776
Total assets less current liabilities: |  | 2,148,657 | 2,089,242
Creditors: amounts falling due after more than one year: | 6 | (71,559) | (117,424)
Provision for liabilities: |  | (21,933) | (21,933)
Total net assets (liabilities): |  | 2,055,165 | 1,949,885
Capital and reserves
Called up share capital: |  | 200 | 200
Profit and loss account: |  | 2,054,965 | 1,949,685
Shareholders funds: |  | 2,055,165 | 1,949,885

The notes form part of these financial statements

# REGENCY MEDICINE LTD.

## Balance sheet statements

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 31 July 2025
and signed on behalf of the board by:

Name: Mr Mahendran Bakeirathan
Status: Director

The notes form part of these financial statements

# REGENCY MEDICINE LTD.

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# REGENCY MEDICINE LTD.

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 2. Employees

| 2024 | 2023
--- | --- | ---
Average number of employees during the period | 47 | 46

# REGENCY MEDICINE LTD.

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 3. Tangible Assets

| Total
--- | ---
Cost | £
At 01 November 2023 | 1,259,716
Additions | 12,086
At 31 October 2024 | 1,271,802
Depreciation |
At 01 November 2023 | 648,250
Charge for year | 55,975
At 31 October 2024 | 704,225
Net book value |
At 31 October 2024 | 567,577
At 31 October 2023 | 611,466

# REGENCY MEDICINE LTD.

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 4. Debtors

| 2024 | 2023
--- | --- | ---
| £ | £
Debtors due after more than one year: | 0 | 0

# REGENCY MEDICINE LTD.

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 5. Creditors: amounts falling due within one year note

Creditors falling due within one year is £236222

# REGENCY MEDICINE LTD.

## Notes to the Financial Statements

for the Period Ended 31 October 2024

## 6. Creditors: amounts falling due after more than one year note

Bank Loan is £71559